{"transactions":[{"id":956985,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-30T21:01:03.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":90000,"price":38.74,"value":3486600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.51 to $39.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":140002,"source":{"system":"sec-edgar","filing":"0001193125-25-337049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525337049/ownership.xml","form_type":"4"}},{"id":961811,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961810,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":139998,"price":39.45,"value":5522921.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":230002,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961809,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":370000,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961808,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":1294205,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T21:58:18.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":270000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-25-009263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025009263/ownership.xml","form_type":"4"}},{"id":1670663,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T21:36:41.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":300000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-007436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024007436/ownership.xml","form_type":"4"}},{"id":2013177,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T20:52:31.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":160000,"derivative":{"exercise_price":13.63,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-23-005141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000089924323005141/doc4.xml","form_type":"4"}},{"id":2423767,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T22:40:01.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":250000,"price":4.9432,"value":1235800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":250000,"derivative":{"exercise_price":7.6,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-22-003465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000089924322003465/doc4.xml","form_type":"4"}}]}